Managing stage 1 hypertension: Consider the risks, stop the progression.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 35500923.
- Also identified by DOI 10.3949/ccjm.89a.21101.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The 2017 American College of Cardiology and American Heart Association Task Force on Clinical Practice Guidelines on the treatment of hypertension recommended lifestyle modification and monitoring every 3 to 6 months for patients with stage 1 hypertension. However, the guidelines did not include recommendations for patients whose blood pressure is unresponsive to lifestyle therapy. The authors review the updated AHA position statement, which is meant to help clinicians manage patients with stage 1 hypertension and a low 10-year risk of atherosclerotic cardiovascular disease.
Medical subject headings
- Cardiology
- Hypertension